Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares OutstandingShort-Term Debt issuances
Ratios

Aytu Biopharma (AYTU) Long-Term Debt Issuances: 2009-2022

Historic Long-Term Debt Issuances for Aytu Biopharma (AYTU) over the last 6 years, with Mar 2022 value amounting to -$73.9 million.

  • Aytu Biopharma's Long-Term Debt Issuances was N/A to -$73.9 million in Q1 2022 from the same period last year, while for Mar 2022 it was $17.5 million, marking a year-over-year change of. This contributed to the annual value of $1.9 million for FY2025, which is 85.72% down from last year.
  • Aytu Biopharma's Long-Term Debt Issuances amounted to -$73.9 million in Q1 2022, which was down 258.34% from $46.6 million recorded in Q4 2021.
  • Over the past 5 years, Aytu Biopharma's Long-Term Debt Issuances peaked at $46.6 million during Q4 2021, and registered a low of -$73.9 million during Q1 2022.
  • Its 3-year average for Long-Term Debt Issuances is $3.6 million, with a median of $2.5 million in 2020.